Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inozyme Pharma

3.99
0.0000
Post-market: 3.98-0.0050-0.13%16:35 EDT
Volume:698.56K
Turnover:2.78M
Market Cap:258.69M
PE:-2.37
High:3.99
Open:3.98
Low:3.98
Close:3.99
Loading ...
Aug 11, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 24, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 07, 2021

Major Issues Report

8-K - Current report
Apr 21, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report